When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?
Before October 2027
KXFDAAPPROVALDATENTLA-LONV-27OCT01
90¢
96¢
54¢
−35¢
6¢
2
668
1,066
in 12mo
active
Before
Jan 1, 2028
early_close_conditionThis market will close and expire early if the event occurs.
event_tickerKXFDAAPPROVALDATENTLA-LONV
exchange_index0
expected_expiration_time2028-01-01T15:00:00Z
expiration_time2028-01-08T15:00:00Z
expiration_value
last_price_dollars0.7200
latest_expiration_time2028-01-08T15:00:00Z
liquidity_dollars0.0000
market_typebinary
no_ask_dollars0.3200
no_bid_dollars0.0800
no_sub_titleBefore 2028
notional_value_dollars1.0000
open_interest_fp143.30
open_time2026-03-24T14:00:00Z
previous_price_dollars0.7200
previous_yes_ask_dollars0.9200
previous_yes_bid_dollars0.6700
price_level_structurelinear_cent
price_ranges1
[0]3
end1.0000
start0.0000
step0.0100
result
rules_primaryIf the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jan 1, 2028, then the market resolves to Yes.
rules_secondary
settlement_timer_seconds1800
statusactive
strike_typecustom
tickerKXFDAAPPROVALDATENTLA-LONV-28JAN01
titleWhen will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?